300206 Stock Overview
Engages in the research, development, manufacture, and sale of medical equipment worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Edan Instruments, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.59 |
| 52 Week High | CN¥15.23 |
| 52 Week Low | CN¥7.13 |
| Beta | 0.14 |
| 11 Month Change | -9.86% |
| 3 Month Change | -21.34% |
| 1 Year Change | -43.04% |
| 33 Year Change | -43.82% |
| 5 Year Change | n/a |
| Change since IPO | -48.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300206 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -3.3% | -1.4% | -2.7% |
| 1Y | -43.0% | -17.5% | -17.4% |
Return vs Industry: 300206 underperformed the CN Medical Equipment industry which returned -17.5% over the past year.
Return vs Market: 300206 underperformed the CN Market which returned -17.4% over the past year.
Price Volatility
| 300206 volatility | |
|---|---|
| 300206 Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300206's share price has been volatile over the past 3 months.
Volatility Over Time: 300206's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,695 | Hao Zhang | www.edan.com |
Edan Instruments, Inc. engages in the research, development, manufacture, and sale of medical equipment worldwide. The company offers diagnostic electrocardiograph (ECG) products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and telemetry and IT products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic doppler systems, central monitoring system, video colposcopes, and biofeedback and stimulation system. It also provides ultrasound systems that include cart-based color doppler, portable color doppler, and B/W ultrasound systems; and in-vitro diagnostics, which comprise hematology analyzers and reagents.
Edan Instruments, Inc. Fundamentals Summary
| 300206 fundamental statistics | |
|---|---|
| Market cap | CN¥4.98b |
| Earnings (TTM) | CN¥119.43m |
| Revenue (TTM) | CN¥1.74b |
41.7x
P/E Ratio2.9x
P/S RatioIs 300206 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300206 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.74b |
| Cost of Revenue | CN¥736.71m |
| Gross Profit | CN¥1.01b |
| Other Expenses | CN¥885.80m |
| Earnings | CN¥119.43m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
| Earnings per share (EPS) | 0.21 |
| Gross Margin | 57.71% |
| Net Profit Margin | 6.86% |
| Debt/Equity Ratio | 0% |
How did 300206 perform over the long term?
See historical performance and comparison